BRNS
Price
$1.01
Change
+$0.02 (+2.02%)
Updated
Jun 6, 11:21 AM (EDT)
Capitalization
39.94M
62 days until earnings call
NEUP
Price
$7.00
Change
-$0.15 (-2.10%)
Updated
Jun 6, 10:47 AM (EDT)
Capitalization
25.08M
Interact to see
Advertisement

BRNS vs NEUP

Header iconBRNS vs NEUP Comparison
Open Charts BRNS vs NEUPBanner chart's image
Barinthus Biotherapeutics
Price$1.01
Change+$0.02 (+2.02%)
Volume$100
Capitalization39.94M
Neuphoria Therapeutics
Price$7.00
Change-$0.15 (-2.10%)
Volume$658
Capitalization25.08M
BRNS vs NEUP Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. NEUP commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Hold and NEUP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BRNS: $0.99 vs. NEUP: $7.15)
Brand notoriety: BRNS and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 17% vs. NEUP: 70%
Market capitalization -- BRNS: $39.94M vs. NEUP: $25.08M
BRNS [@Biotechnology] is valued at $39.94M. NEUP’s [@Biotechnology] market capitalization is $25.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than NEUP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 5 TA indicator(s) are bullish while NEUP’s TA Score has 6 bullish TA indicator(s).

  • BRNS’s TA Score: 5 bullish, 5 bearish.
  • NEUP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NEUP is a better buy in the short-term than BRNS.

Price Growth

BRNS (@Biotechnology) experienced а -10.00% price change this week, while NEUP (@Biotechnology) price change was +10.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.10%, and the average quarterly price growth was +3.20%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

NEUP is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS($39.9M) has a higher market cap than NEUP($25.1M). NEUP YTD gains are higher at: 108.455 vs. BRNS (-18.046). NEUP has higher annual earnings (EBITDA): -14.17M vs. BRNS (-58.89M). BRNS has more cash in the bank: 99.1M vs. NEUP (4.35M). NEUP has less debt than BRNS: NEUP (199K) vs BRNS (11.9M). BRNS has higher revenues than NEUP: BRNS (15M) vs NEUP (663K).
BRNSNEUPBRNS / NEUP
Capitalization39.9M25.1M159%
EBITDA-58.89M-14.17M416%
Gain YTD-18.046108.455-17%
P/E RatioN/A0.38-
Revenue15M663K2,262%
Total Cash99.1M4.35M2,281%
Total Debt11.9M199K5,980%
TECHNICAL ANALYSIS
Technical Analysis
BRNSNEUP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 5 days ago
89%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMG65.016.39
+10.90%
Scotts Miracle-Gro Company (The)
PRM12.650.40
+3.27%
Perimeter Solutions Inc
WIT2.860.02
+0.70%
Wipro Limited
OCX2.93N/A
N/A
Oncocyte Corp
PBFS11.31-0.08
-0.70%
Pioneer Bancorp

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
N/A
SYBX - NEUP
64%
Loosely correlated
-0.81%
BRNS - NEUP
50%
Loosely correlated
-8.33%
CMND - NEUP
31%
Poorly correlated
+0.65%
ENSC - NEUP
31%
Poorly correlated
-2.31%
SLNO - NEUP
27%
Poorly correlated
-2.47%
More